Home
Corbett USA

Corbett USA Market Share Analysis for May 2026

Health > Health - Other

Domaincorbett.com

Year Founded1960

Employees51 - 200

Annual Revenue$25M - $50M

Corbett USA

Corbett USA (including company regionals)

corbett.com

See more website traffic and engagement information

Corbett USA Revenue up to May 2026 is 25M - 50M

revenue generated by Corbett USA top domains

Corbett USA top domains revenue over 3 years

Revenue for Corbett USA top domains

corbett.com25M - 50M

See more with Sales Intelligence

Total visits to Corbett USA's top domains

Understand Corbett USA market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Corbett USA's top domains

Analyze Corbett USA engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Corbett USA's top domains

See how Corbett USA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Corbett USA top competitors by domain

Top similar sites in May 2026, ranked by their affinity

gene2drug.comCompany NameGene2drugEmployees51 - 200HQUnited States, Virginia, ArlingtonAnnual revenue$50M - $75MTotal visits--Health > Health - Other

Top technologies used by Corbett USA

These are the website technologies, by industry, used by Corbett USA top domains

Mobile (2)

Meta Viewport

Audio Video Media (1)

YouTube

Content Management System (1)

Web Dot Com

Conversion & Analytics (1)

Google Analytics

More Technologies

1

See all

News & Signals from Corbett USA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCorbett receives award 2021 Travellers’ Choice Best of the Best award for Top Hotels in India.Lemon Tree Premier, Corbett wins 2021 Travellers’ Choice Best of the Best award for Top Hotels in India, ranking eighth out of 25.

NewsCorbett partners with Moderna.Corbett’s team at the NIH partnered with Moderna to create a vaccine with an efficacy rate of nearly 95%, developing it on a much faster timeline than previous coronavirus vaccines.